Dayton Area Chamber of Commerce et al v. Becerra et al
Case Number:
3:23-cv-00156
Court:
Nature of Suit:
Constitutional - State Statute
Judge:
Firms
- Baker & Hostetler
- Cook Allen
- Cooper Elliott
- Gittes Law Group
- Hagens Berman
- Karon LLC
- King & Spalding
- Porter Wright
Companies
- AARP Inc.
- American College of Physicians
- American Public Health Association
- American Society of Hematology
- Center for American Progress
- Public Citizen Inc.
Government Agencies
Sectors & Industries:
-
August 09, 2024
Medicare Drug Price Suit Nixed Over 'Forum Shopping' In Ohio
The Department of Health and Human Services has notched yet another win in litigation challenging the constitutionality of the Medicare drug price negotiation program, securing the dismissal of a suit brought by several chambers of commerce.
-
February 15, 2024
HHS Targets Biz Group's Standing In Bid To End Medicare Suit
The Biden administration has asked an Ohio federal judge to dismiss a lawsuit challenging the Medicare price negotiation program, contending that the local business group serving as lead plaintiff lacks standing to sue.
-
December 18, 2023
HHS Says Chambers Have No Place In Drug Price Dispute
Local business groups still haven't explained why they have a stake in Medicare's effort to negotiate lower prices with drugmakers, the U.S. Department of Health and Human Services said in a federal filing in Ohio Friday.
-
October 06, 2023
Mapping Big Pharma's Blitz On Medicare Drug Price Talks
Lawsuits from Big Pharma and big business challenging Medicare's new power to negotiate drug prices are hurtling toward pivotal tests of lofty legal theories and the Biden administration's creative efforts to save its signature health care accomplishment. Here, Law360 explores the litigation landscape in a detailed map that will be updated as the saga evolves.
-
September 29, 2023
US Chamber Loses Bid To Stop Medicare Drug Price Talks
An Ohio federal judge on Friday rejected a request from the U.S. Chamber of Commerce and three business groups for a temporary block on Medicare drug price negotiations.
-
September 15, 2023
Chamber Urges Court To Block Medicare Drug Price Program
The U.S. Chamber of Commerce and a trio of state business groups urged an Ohio federal judge Friday to temporarily block the new Medicare drug price negotiation program, arguing that the Inflation Reduction Act provision is a price-setting scheme dressed "in the garb of negotiations."
-
September 01, 2023
Novartis Joins Legal Fray After Price Negotiation List Unveiled
Novartis Pharmaceuticals Corp. on Friday joined the growing list of pharmaceutical companies challenging the Inflation Reduction Act, filing suit in New Jersey federal court just days after the Biden administration revealed the list of drugs in the inaugural round of Medicare price negotiations.
-
August 25, 2023
AARP Fights Block Of Medicare Drug Price Negotiations
The AARP urged an Ohio federal judge not to stop the federal government from negotiating the prices of certain prescription drugs paid for under the Medicare program, arguing that an injunction sought by the U.S. Chamber of Commerce would keep prices unsustainably high to the detriment of the AARP's members and the general public.
-
August 14, 2023
Drug Negotiation Suits Reflect Lobbying Failures, HHS Says
A barrage of legal challenges to landmark legislation empowering Medicare to negotiate drug prices is little more than a failed lobbying campaign "masquerading as constitutional theory," the U.S. Department of Health and Human Services said in its first official rebuttal in the high-stakes litigation.
-
July 21, 2023
The Litigation Jolting Health & Life Sciences In 2023's 2nd Half
A head-spinning spree of rulings and new lawsuits in 2023's first half is reverberating across the health care industry and auguring a dizzying denouement in the year's final months that may well upend assumptions about drug prices and approvals, the False Claims Act and the powers of federal regulators.